New discovery in cancer progression paves way to cancer drugs with fewer side effects
Scientists from A*STAR's Institute of Molecular and Cell Biology (IMCB) and Genome Institute of Singapore (GIS), as well as the NUS Cancer Science Institute of Singapore (CSI Singapore), National Cancer Center Singapore (NCCS) ...
Jul 20, 2022
0
70
